Keywords: Bayer, Growth plans, Japan, Relief donations, Drugs in research
Bayer celebrates 100 years in Japan, planning continued growth there despite difficult conditions
Article | 05 October 2011
Germany’s pharma, and material and crop sciences group Bayer (BAY: DE) says it plans to expand its business ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
